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1. adults with Down syndrome present with a high level of clinical and functional complexity 
2. a ‘geriatric approach’ based on a comprehensive assessment and management could likely 
deliver the highest quality care in these subjects 
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Abstract 
Background: Down syndrome (DS) is characterised by premature aging that affects selected organ systems, 
and persons with this condition can present patterns of comorbidities and deficits often observed in the 
older population without DS. However, information on the characteristics of adult persons with DS is 
limited.  
Objective: Describe characteristics of adults with DS collected with a standardised, comprehensive 
assessment instrument.  
Design: Cross sectional study 
Setting and Subjects: 430 adults with DS (age range 18/75 years) from 3 countries (Italy, n=95; United 
States, n=175; Canada, n=160). 
Methods: A standardised assessment instrument (interRAI Intellectual disability, or interRAI ID) was used to 
assess sample characteristics. 
Results: Mean age ranged from 35.2 (SD 12.0) years in the US sample to 48.8 years (SD 9.0) in the Canadian 
sample. Most participants in the Italian and US sample were living in private homes, while more than half of 
those in the Canadian sample were institutionalised. Prevalences of geriatric conditions, including cognitive 
deficits, disability in the common activities of daily living, symptoms of withdrawal or anhedonia, aggressive 
behaviour, communication problems, falls and hearing problems were high in the study sample. 
Gastrointestinal symptoms, skin and dental problems and obesity were also frequently observed. 
Conclusions: Adults with DS present with a high level of complexity, which may suggest the need for an 
approach based on a comprehensive assessment and management that can provide adequate care. Further 
research is needed to understand better the effectiveness of such an approach in the DS population. 
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Introduction 
Life expectancy of persons with Down Syndrome (DS) has progressively increased in the last 
century, from 9 years in 1929 to almost 60 years in 2013(Englund et al., 2013; Glasson et al., 2002; Yang et 
al., 2002). Such an exceptional increase has led some investigators to forecast that in a few decades 
persons with DS could live as long as the general population(Bittles and Glasson, 2004). Given these 
epidemiological changes, DS should be no longer considered a “paediatric” condition, but rather a 
condition that affects the whole life span. DS is considered a “segmental” progeroid syndrome, in which a 
premature aging affects selected organ systems, and persons with this condition might present patterns of 
comorbidities often observed in the older population(Carfì et al., 2017; Picciotti et al., 2017; Real de Asua et 
al., 2015; Schoufour et al., 2016; Vetrano et al., 2015). The clinical picture is often complicated by the 
presence of functional deficits, behavioural symptoms and nutritional and social problems(Carfì et al., 
2014). This level of complexity requires the use of a comprehensive approach, in order to have a full 
understanding of the issues and needs of adults with DS(Carfì et al., 2015; Covelli et al., 2016). Such an 
approach is commonly adopted in geriatric medicine. The aim of the present study is understanding 
whether the use of a standardised comprehensive assessment tool on a sample of adults with DS from 3 
countries (Italy, United States (US) and Canada) could provide useful information on their functional 
impairment and comorbidities. 
 
Materials and Methods 
Participants  
Data on participants with DS were collected in three countries (Italy, US and Canada). 
Italy 
Participants were adults with DS, aged 18 or older, assessed at the Day Hospital (DH) of the Geriatric 
Department of Policlinico A. Gemelli, Università Cattolica del Sacro Cuore in Rome. No specific inclusion 
criterion was required to be admitted to the DH except for aged 18 or older. Participants did receive a 
clinical assessment, following a standardised protocol, including blood sample, electrocardiogram, 
ophthalmologist, dentist and ear-nose-throat specialist consultation, nutrition status and body composition 
measurement, echocardiography, and a comprehensive assessment by the use of the InterRAI Intellectual 
Disability (ID) instrument. Adults with DS were directed to the DH through DS associations and from family 
physicians. Data on 95 adults with DS that completed clinical assessment are presented in this manuscript.  
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US 
The US data represents the full 2013 state-wide census of adults (i.e., 18+ years old) receiving 
intellectual/developmental disabilities services funded by the State of Arkansas Division of Developmental 
Disability Services, with assessments using the interRAI ID performed by trained professional assessors 
under contract to the state.  These data include people who lived in private homes, staff homes, 
community residential settings, state Human Development Centers, homeless persons, and people 
classified as living in “other” arrangements.  We report here on the 175 persons with DS in this population. 
Canada 
Data from Canada are based on studies of adults with intellectual or developmental disabilities living in the 
community and specialised institutions(Langlois and Martin, 2008). The community data comes from two 
separate studies, one of which focused exclusively on adults aged 50 years or more (the other study sample 
included adults younger than 50 years). All persons living in Ontario’s institutions were assessed, so the 
data represent the full population; note that these specialised institutions have since closed. Assessments 
were collected by front-line staff who had received extensive training related to the interRAI ID. A total of 
160 adults with Down syndrome were identified in the data.  
 
InterRAI ID 
Adults with DS in the study were assessed using the interRAI ID instrument, which contains over 350 
data elements including socio-demographic variables, numerous clinical items about physical and cognitive 
status, functioning, behaviours, as well as signs, symptoms, syndromes, and treatments being 
provided(Martin et al., 2007). Items are completed by an assessor based on history and basic signs and 
symptoms (e.g. face expressions, disruptive behaviours, pain frequency and intensity, etc.) collected directly 
from the subject or by an informant; a number of questions are asked directly to the subject concerning 
his/her preferences, outlook and wellbeing. Informants are selected among the closest relatives (parents or 
siblings) or long standing caregivers. All assessors followed a standardised training for administration of the 
interRAI ID. In US and Canada data, collection was performed by trained assessors in the field of intellectual 
and developmental disabilities, and by trained physicians in Italy. 
  
Clusters of items are set up in algorithms and scales to deliver clinically relevant diagnostic triggers 
to inform subsequent clinical evaluation; such scales have proven internally consistent and valid among 
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adults with ID(Langlois and Martin, 2008; Martin et al., 2007). The cognitive performance scale (CPS) informs 
on current cognitive status(Morris et al., 1994). The scale scores were categorised into mild to moderate 
cognitive impairment (CPS scores 2 to 4) and severe cognitive impairment (CPS scores ≥ 5). The seven point 
Activities of Daily Living (ADL) Hierarchy Scale informs on functioning - i.e., independence in ADLs. Score  ≥ 2 in 
the ADL Hierarchy Scale was used to identify participants requiring assistance in ADL(Morris et al., 1999).  The 
Depression Rating Scale (DRS) was used to assess the presence of depressive symptoms with scores ≥ 3  
indicative of depression(Burrows et al., 2000).  A score from 1 to 4 on the Aggressive Behaviour Scale was 
used to define mild/moderate aggressive behaviour and scores ≥ 5 to define severe aggressive 
behaviour(Frederiksen et al., 1996).  On the Social Withdrawal Scale, scores ≥ 1  identified symptoms of 
withdrawal or anhedonia(Rios and Perlman, 2017).  Finally, mild/moderate communication problems were 
defined by Communication Scale scores from 2 to 5 and severe problems by scores from 6 to 8(Frederiksen 
et al., 1996).  
Descriptive analyses are present in this manuscript. Data were analysed using SPSS (version 18.0) for the 
Italian data, and SAS (Version 9.3) for the US and Canada data. 
 
Results 
Mean age of persons with DS ranged from 35.2 (SD 12.0) years in the US sample to 48.8 years (SD 
9.0) in the Canadian sample (Table 1). Most participants in the Italian and US sample were living in private 
homes, while more than half of those in the Canadian sample were institutionalised; these differences 
being related to different sample recruitment and not to different social care models. Geriatric conditions 
occurred at high rates in the study samples, including cognitive deficits, ADL disability, symptoms of 
withdrawal or anhedonia, aggressive behaviour, communication problems, falls and hearing problems, 
while rate of urinary and faecal incontinence varied across study sites, being more commonly observed in 
the US and Canadian samples. Gastrointestinal symptoms, and skin and dental problems were also 
frequently observed, while acute conditions such as psychiatric symptoms (which includes delusions, 
hallucinations or abnormal thought process), dizziness and pain occurring in the three days before the 
assessment were uncommon. Obesity (Body Mass Index, BMI ≥ 30 kg/m2) was also highly prevalent (BMI 
data not measured in Canada). Prevalence of physicians visits in the last 90 days varied across study sites 
ranging from 37.9% in Italy to 81.1% in the US. 
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Discussion 
We present here data on a large sample of adults with DS which demonstrate that they present 
with a high level of comorbidity and complexity. Despite variation in different study sites related to the 
enrolment procedures adopted, the data clearly show that adults with DS are characterised by presence of 
functional and cognitive impairments, and common occurrence of mood disorders, oral and nutritional 
problems, and geriatric syndromes (including anhedonia, aggressive behaviour, falls, incontinence, 
communication and hearing problems) - and at fairly young mean ages. This is in line with previous studies 
showing higher prevalences of disease with trajectories of precocious onset(Glasson et al., 2014). However, 
no previous study has attempted to picture the prevalence of disease and functional impairment in this 
population both comprehensively, i.e. with a single multidimensional instrument, and transnationally.  
The approach to deliver the highest quality care to this population is still being discussed, and as a 
result, persons with DS resulting in complex needs may not receive appropriate care(Glasson et al., 2014).  
Further, adults with DS and their families often face hard times initiating the transition from paediatric to 
adult-based services, and the responsibility for the care of adults with DS and other congenital disabilities is 
poorly defined(Jensen and Davis, 2013). In the current literature, there seem to be two different 
approaches. Some advocate for care by general practitioners(Jensen and Bulova, 2014), though yet there 
remains controversy whether  general practitioners are sufficiently knowledgeable, experienced, or even 
available to administer the proper levels of care for adults with DS(Bittles and Glasson, 2004; Henderson et 
al., 2007; Jensen et al., 2013). The complexity of needs of adults with DS often means that there is an 
increase in workload for health professionals in the primary care setting. For this reason, an approach that 
favours care based on comprehensive assessment and close interaction between general practitioners and 
management team specialised in the area of DS have been proposed(Carfì et al., 2015, 2014). This approach 
has been adopted and tested in geriatric medicine and it was shown to be successful independently of 
patient age(Ellis et al., 2011).  
Comprehensive, multidimensional assessment is key to full evaluation and understanding of 
complexity. It provides information on the various co-morbidities, syndromes, functional and cognitive 
deficits experienced by adults with DS, which are not all covered by the traditional medical assessment. 
Comprehensive assessment, therefore, allows a more specific and sensible care plan to be developed. As 
presented in this study, the adoption of a comprehensive assessment instrument specifically designed for 
persons with intellectual disabilities (interRAI ID), might lead to better identification of problems or 
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conditions associated with DS and improve diagnostic accuracy; it may also lead to initiation of needed 
services in a timely fashion.  
Given the similarities between complex older adults in the general population and adults with DS, a 
‘geriatric approach’ based on a comprehensive assessment and management likely represents the best 
intervention to optimise medical treatment, improve prognosis, restore, maintain and maximise functional 
autonomy, compensate for the loss of autonomy with an appropriate support, and, hopefully, improve 
quality of life in adults with DS. Further research is needed that examines the impact of such assessment on 
services and outcomes among adults with DS. 
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Table 1. Sample characteristics 
 
 Italy (n=95) United States (n=175) Canada (n=160) 
Demographics    
Age, mean ± SD (range) 38.1 ± 13.3 (19/65) 35.2 ± 12.0 (18/62) 48.8 ± 9.0 (21/75) 
Age > 40 y, n (%) 41 (43.2%) 58 (33.1%) 23 (14.4%) 
Female, n (%) 47 (49.5%) 65 (37.1%) 62 (39.2%) 
Usual residential status 
   Private home 
   Group home  
   Institution   
 
85 (89.4%) 
10 (10.6%) 
- 
 
146 (83.5%) 
12 (6.9%) 
17 (9.7%) 
 
- 
71 (44.4%) 
89 (55.6%) 
Geriatric conditions    
Cognitive statusa 
   Mild/moderate impairment  
   Severe impairment  
 
60 (63.2%) 
14 (14.7%) 
 
129 (73.7%) 
35 (20.0%) 
 
67 (41.9%) 
74 (46.3%) 
Assistance required in ADLb 27 (28.4%) 99 (56.6%) 101 (63.1%) 
Depressionc 22 (23.2%) 85 (48.6%) 18 (11.3%) 
Symptoms of withdrawal/anhedoniad 23 (24.2%) 62 (35.4%) 45 (28.1%) 
Aggressive behavioure 
   Mild/moderate 
   Severe 
 
25 (26.3%) 
1(1.1%) 
 
81 (46.3%) 
16 (9.1%) 
 
64 (40.0%) 
9 (5.6%) 
Communication problemsf 
   Mild/moderate impairment  
   Severe impairment  
 
57 (60%) 
9 (9.5%) 
 
98 (56.0%) 
63 (36.0%) 
 
71 (44.4%) 
70 (43.8%) 
At least one fall in the last 90 days 12 (12.7%) 30 (17.1%) 14 (8.8%) 
Urinary incontinence  7 (7.4%) 49 (28.0%) 68 (42.5%) 
Faecal incontinence  3 (3.2%) 49 (28.0%) 45 (28.1%) 
Hearing problemsg 28 (29.5%) 47 (26.9%) 34 (21.3%) 
Symptoms & other conditions    
Painh 
   No/less than daily 
   Daily but not severe 
   Daily severe 
 
82 (94.3) 
4 (4.6) 
1 (1.1) 
 
155(88.6%) 
16(9.1%) 
4(2.3%) 
 
148 (92.5%) 
10 (6.3%) 
1 (0.6%) 
Dizziness in the last 3 days 5 (5.3%) 7 (4.0%) 3 (1.9%) 
Gastrointestinal symptomsi in the last 3 
days 
38 (40%) 47 (26.9%) 22 (17.6%) 
Psychiatric symptomsj in the last 3 days 5 (5.3%) 22 (12.6%) 7 (4.4%) 
Skin problemsk 28 (29.5%) 130 (74.3%) 77 (49.0%) 
Nutrition    
Dental problemsl 63 (66.3%) 40 (22.9%) 26 (16.4%) 
Body mass Index (kg/m2)m 
   < 18.5 
   18-5-25 
   25-30 
   30 or more 
 
1 (1.1%) 
41(43.2%) 
27 (28.4%) 
25 (26.3%) 
 
3 (1.7%) 
34 (19.4%) 
44 (25.1%) 
94 (53.7%) 
 
- 
- 
- 
- 
Visits and admissions (last 90 days)n    
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Physician visits 36 (37.9%) 142 (81.1%) 107 (66.9%) 
Inpatient acute hospital admission 5 (5.3%) 6 (3.4%) 2 (1.3%) 
Emergency room visits 8 (8.4%) 10 (5.7%) 2 (1.3%) 
Visits with mental health physician 3 (3.2%) 27 (15.4%) 14 (8.8%) 
 
a. Mild/moderate cognitive impairment is defined by Cognitive Performance Scale score 2–4, severe impairment by Cognitive 
Performance Scale score 5–6. 
b. Assistance required is defined by ADL hierarchical scale score 2 or higher. 
c. Depression Rating Scale score ≥ 3. 
d. Social Withdrawal Scale score≥ 1  
e. Mild/moderate aggressive behaviour is defined by Aggressive Behaviour Scale score 1–4, severe aggressive behaviour by 
Aggressive Behaviour Scale 5 or more. 
f. Mild/moderate communication problems are defined by Communication Scale score 2–5, severe problems by Communication 
Scale score 6–8. 
g. Defined as a difficulty to hear (with hearing appliance normally used) at least in some environments (e.g., when person speaks 
softly or is more than 2 metres away). 
h. Person complains or shows evidence of pain (including grimacing, teeth clenching, moaning, withdrawal when touched, or other 
nonverbal signs suggesting pain) 
i. Including acid reflux or constipation or diarrhoea or vomiting.  
j. Including delusion or hallucinations or abnormal thought process. 
k. Including bruises or rashes or itching or mottling or herpes zoster or intertrigo or eczema. 
l. Including presence of broken, fragmented, loose, or otherwise nonintact natural teeth or gum (soft tissue) inflammation or 
bleeding adjacent to natural teeth or tooth fragments.  
m. BMI data not collected in Canada 
n. Used the specified health service at least once in the last 90 days 
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